Exploring the adoption of less restricted criteria for respiratory syncytial virus prophylaxis in late preterm infants: insights from a retrospective analysis

• Main Authors: Vito Mondì (Author), Piermichele Paolillo (Author), Manuela Bedetta (Author), Natalia Lucangeli (Author), Simonetta Picone (Author)
• 格式: 圖書
• 出版: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

BackgroundPreterm infants born between 33 and 35 weeks of gestational age (wGA) have been considered a "major underserved population" and ineligible to receive palivizumab (PLV), the only drug authorized to date for respiratory syncytial virus (RSV) prophylaxis, by current international gu...